EUVIMEDEUVIMED entdecken
Open Access

Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications

Judith Arres iD, Santosh Elavalli iD, Shalini Behl, Daniel Matias Sanchez iD, Ayesha Al Ali, Abdelrahman Ahmed Yehia Abdelaziz Saad, Azza Attia, Cyla Minas, Sharika Pariyachery, Shariq Ahmed, Fatmah Aldhuhoori, Nitu Thulasidharan und 16 weitere

Genome Research · 2026

DOI: 10.1101/gr.280134.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, 2026. Verfasst von Judith Arres und 27 weiteren Autor:innen. Beteiligte Einrichtung: M42, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Nanopore Sequencing, Genomics, High-Throughput Nucleotide Sequencing, Sequence Analysis, DNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, National Institutes of Health, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-read sequencing (LRS) technologies, namely, Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio), have emerged as promising solutions to overcome the limitations of short-read sequencing (SRS). Nevertheless, the still higher sequencing error rates compared with SRS, need for customized pipelines, rapidly updating software, and incipient scalability continue to present challenges for adopting ONT in standard clinical practice. Here we assess the performance of ONT (R9 and R10 chemistries) in comparison to Illumina and MGI across 17 well-characterized reference samples with 11 clinical variants representing nine different genetic diseases. To enable this, we have implemented a production-ready pipeline including SNV, indel, STR, SV, and CNV detection, alongside reporting key summary metrics to ensure high-quality data at the production sequencing level. Our results show high accuracy of ONT across SNVs ( F -score 0.978–0.983) and SVs ( F -score = 0.75) but still weaknesses across indels ( F -score 0.659–0.758). However, we highlight that ONT accurately detected all four pathogenic indels as well as the performance improvement in exons and with the newer R10 chemistry. We further demonstrated the importance of long reads to detect clinically impactful variants such as a FMR1 pathogenic expansion, often misclassified by SRS as being in the premutation range. Our multiplatform analysis and Sanger validation uncovered a 1 bp error in the Coriell annotation for a cystic fibrosis–causing indel in GM07829. This work underscores the growing readiness of ONT for clinical applications, highlighting both its advancements and its potential for broader adoption in clinical genomics and large-scale operations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanopore SequencingGenomicsHigh-Throughput Nucleotide SequencingSequence Analysis, DNAHumansINDEL MutationPolymorphism, Single NucleotideDNA Copy Number VariationsGenome, Human

Autor:innen und Institutionen

  • M42, Abu Dhabi, United Arab Emirates.
  • Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas 77030, USA.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
  • Department of Computer Science, Rice University, Houston, Texas 77251-1892, USA.
  • M42, Abu Dhabi, United Arab Emirates; jquilez@m42.ae.

ORCID-Profile: Judith Arres, Santosh Elavalli, Daniel Matias Sanchez, Luis F Paulin, Javier Quilez

Förderung

  • NHGRI NIH HHS
  • National Institutes of Health
  • NIH

Zitieren

APA

Arres, J., Elavalli, S., Behl, S., Matias Sanchez, D., Al Ali, A., Saad, A. A. Y. A., Attia, A., Minas, C., Pariyachery, S., Ahmed, S., Aldhuhoori, F., Thulasidharan, N., Katagi, G., Soliman, O., Purohit, S., Kusuma, V., Cardenas, R., Cardoso, T., Paulin, L. F., …, & Quilez, J. (2026). Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications. Genome Research. https://doi.org/10.1101/gr.280134.124

Vancouver

Arres J, Elavalli S, Behl S, Matias Sanchez D, Al Ali A, Saad AAYA, et al. Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications. Genome Research. 2026. doi:10.1101/gr.280134.124

BibTeX
@article{Arres2026,
  author = {Arres, Judith and Elavalli, Santosh and Behl, Shalini and Matias Sanchez, Daniel and Al Ali, Ayesha and Saad, Abdelrahman Ahmed Yehia Abdelaziz and Attia, Azza and Minas, Cyla and Pariyachery, Sharika and Ahmed, Shariq and Aldhuhoori, Fatmah and Thulasidharan, Nitu and Katagi, Gurunath and Soliman, Omar and Purohit, Shilp and Kusuma, Vinay and Cardenas, Raony and Cardoso, Thyago and Paulin, Luis F and Sanio, Philippe and Mafofo, Joseph and Wu, Haiguo and Zvereff, Val and El-Khani, Albarah and Al Marzooqi, Fahed and Magalhães, Tiago R and Sedlazeck, Fritz J and Quilez, Javier},
  title = {Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications},
  journal = {Genome Research},
  year = {2026},
  doi = {10.1101/gr.280134.124}
}
Kostenlos starten →